Strategic partnerships VHIO is a premier cancer research center embedded in a major hospital campus with strong translational science ties, presenting opportunities for clinical collaboration, sponsored research, and co-developed diagnostics or therapeutics with industry sponsors seeking real-world oncology data and access to patient cohorts.

Precision oncology focus VHIO emphasizes precision oncology and tackling resistant and undruggable tumors, signaling demand for targeted therapies, biomarker-driven studies, companion diagnostics, and data analytics partnerships to accelerate personalized treatment development.

Recent recognitions Renewed Severo Ochoa Centre of Excellence status and notable award recognition for researchers underscore VHIO’s credibility and visibility, making it an attractive partner for joint grants, funded research programs, and strategic industry collaborations.

Innovation in diagnostics Current initiatives include a diagnostic test for breast cancer from breast milk, indicating VHIO’s interest in novel, noninvasive diagnostics and potential collaboration for assay development, regulatory pathways, and commercialization support.

Industry collaboration Active partnerships with major pharma such as Roche for first-in-human trials and engagement in multi-institution consortia (e.g., PragmaTIL) suggest opportunities for co-development programs, clinical trial sponsorship, and access to VHIO’s computational and genomic capabilities.